Valuation: AcuCort AB

Market Cap 136M 14M 12.3M 11.33M 10.6M 19.87M 1.32B 20.24M 52.67M 651M 52.59M 51.44M 2.26B P/E 2024
-3.61x
P/E 2025 -5x
Enterprise Value 109M 11.22M 9.86M 9.08M 8.49M 15.93M 1.06B 16.22M 42.21M 522M 42.14M 41.22M 1.81B EV / Sales 2024
11.3x
EV / Sales 2025 17x
Free-Float
36.58%
Yield 2024 *
-
Yield 2025 -
1 day-3.01%
1 week+28.60%
Current month-15.94%
1 month-15.45%
3 months-7.79%
6 months+1.93%
Current year-3.33%
1 week 0.46
Extreme 0.455
0.67
1 month 0.4
Extreme 0.401
0.72
Current year 0.4
Extreme 0.401
0.95
1 year 0.4
Extreme 0.401
0.95
3 years 0.33
Extreme 0.327
1.45
5 years 0.33
Extreme 0.327
4.98
10 years 0.33
Extreme 0.327
9.5
Manager TitleAgeSince
Chief Executive Officer 55 08/08/2020
Corporate Officer/Principal 53 13/10/2025
Director TitleAgeSince
Director/Board Member 68 07/02/2017
Chairman 63 31/12/2017
Director/Board Member 79 31/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
-3.01%+28.60%-24.08%-59.72% 14M
-3.50%-5.61%-24.58%-33.65% 13.5B
-3.76%-6.40%-32.82%-32.82% 6.58B
+0.72%+2.29%-17.98%-11.55% 5.76B
-2.75%-5.98%-20.99%-40.46% 3.34B
-0.69%-1.52%-26.52%-44.68% 3.26B
-1.42%-3.68%-37.95%-13.91% 3.22B
+0.06%-1.42%-0.81%-43.10% 2.67B
+0.02%-0.27%-15.79%-3.08% 2.44B
+1.47%-6.79%+84.61% - 2.46B
Average -1.29%-0.32%-11.69%-31.44% 4.32B
Weighted average by Cap. -1.85%-3.71%-17.64%-29.07%

Financials

2024 2025
Net sales 7.72M 795K 698K 643K 601K 1.13M 74.99M 1.15M 2.99M 36.97M 2.98M 2.92M 128M 6.68M 688K 605K 557K 521K 977K 64.94M 995K 2.59M 32.01M 2.58M 2.53M 111M
Net income -17.4M -1.79M -1.57M -1.45M -1.36M -2.54M -169M -2.59M -6.74M -83.34M -6.73M -6.58M -290M -26.19M -2.7M -2.37M -2.18M -2.04M -3.83M -255M -3.9M -10.14M -125M -10.13M -9.91M -436M
Net Debt -2.77M -285K -251K -231K -216K -405K -26.94M -413K -1.07M -13.28M -1.07M -1.05M -46.15M -27.01M -2.78M -2.44M -2.25M -2.11M -3.95M -262M -4.02M -10.46M -129M -10.45M -10.22M -450M
Logo AcuCort AB
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Employees
5
Date Price Change Volume
25/06/26 SEK 0.5800 -3.01% 458,124
24/06/26 SEK 0.5980 +3.82% 87,227
23/06/26 SEK 0.5760 +3.97% 364,910
22/06/26 SEK 0.5540 +22.84% 1,661,462
18/06/26 SEK 0.4510 -32.69% 3,438,034
  1. Stock Market
  2. Stocks
  3. ACUC Stock